
Odiglim-M 2mg/500mg Tablet
Marketer
Zinnia Life Sciences
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Overview Odiglim-M 2mg/500mg Tablet
Diabetol Duo 2mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Administer Diabetol Duo with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your glycemic response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your healthcare provider. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Maintain regular mealtimes and carry readily available glucose sources (e.g., sugary snacks or juice) to mitigate this risk. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your doctor before initiating treatment. Consult your physician before use during pregnancy or breastfeeding. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.
Primary Ingredients of Odiglim-M 2mg/500mg Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Odiglim-M 2mg/500mg Tablet
Managing type 2 diabetes
Major Benefits of Odiglim-M 2mg/500mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Odiglim-M 2mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
Common Side effects of Odiglim-M 2mg/500mg Tablet:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Odiglim-M 2mg/500mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or breaking it. The Odiglim-M 2mg/500mg tablet should be administered with a meal.
How Odiglim-M 2mg/500mg Tablet works:
Odiglim-M 2mg/500mg tablets combine glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose uptake, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Odiglim-M 2mg/500mg tablets with alcohol is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Odiglim-M 2mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice before taking this drug.
Breast feedingUNSAFE
Breastfeeding mothers should not take Odiglim-M 2mg/500mg tablets. Evidence indicates potential infant harm from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Odiglim-M 2mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Odiglim-M 2mg/500mg tablets. Physician consultation is recommended. Routine monitoring of renal function is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Odiglim-M 2mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Odiglim-M 2mg/500mg Tablet :
Should you forget a dose of Odiglim-M 2mg/500mg Tablet, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Odiglim-M 2mg/500mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes medication |
